Drug intelligence / Profile preview

Leukotide

Development stage
Unknown
Lead developer
Partner Therapeutics
Modality
Small Molecules
01

Overview

Leukotide is a dietary supplement and nutraceutical product composed of a specific mixture of nucleotides, including adenosine, cytidine, guanosine, uridine, and inosine. It is primarily marketed to support the immune system by providing the necessary precursors for the rapid synthesis of leukocytes (white blood cells), which is particularly relevant during periods of physiological stress, infection, or recovery from medical treatments like chemotherapy. Nucleotides are essential for cell division and protein synthesis, and while the body can synthesize them de novo, exogenous supplementation is thought to reduce the metabolic burden on tissues with high turnover rates, such as the intestinal epithelium and immune cells. Leukotide is used in both human health contexts for immune support and in animal nutrition to improve growth and disease resistance in livestock and aquaculture.

Brand names
Leukotide
Other names
nucleotide complexnucleotide supplement

Beyond the preview

Go deeper on Leukotide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leukotide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call